Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
Titel:
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
Auteur:
Gluz, O. Nitz, U.A. Harbeck, N. Ting, E. Kates, R. Herr, A. Lindemann, W. Jackisch, C. Berdel, W.E. Kirchner, H. Metzner, B. Werner, F. Schütt, G. Frick, M. Poremba, C. Diallo-Danebrock, R. Mohrmann, S.